|
hiv-aids
 9/9/2010 Opinions: U.S. Commitment To Global Fund; Innovative Financing; Global Food Security; Aid For Pakistan
U.S...
9/9/2010 Also In Global Health News: Mass Rape In Congo; Malaria Research At Walter Reed; Nevirapine For Infants; Aid To Pakistan Improved Trust; More
U.N. Now Estimates 500 Raped In Congo "Approximately 500 women were raped in eastern Congo in July and August," U.N. officials said Tuesday, revising an earlier report of 242 victims, according to the New York Times...
9/9/2010 AIDS Programs Reach Out To African Immigrant Community
The Seattle Times reports on educating people about AIDS in the African immigrant community in Seattle. "For African immigrants, who come from countries with high rates of HIV and AIDS, talking about their own diagnosis is often taboo...
9/9/2010 Team Of Scientists Issues HIV Vaccine Strategy
The Council of the Global HIV Vaccine Enterprise on Tuesday released a new strategy for HIV vaccine research, which marked "the culmination of an 18-month effort that included the input of 400 scientists worldwide," VOA News reports (DeCapua, 9/7). The strategy, published as a Commentary (...
9/9/2010 Education More Important Than Knowledge In Stopping Spread Of HIV In Africa
Simply teaching people the facts about how to protect themselves from HIV may not be enough to prevent the spread of AIDS in Africa, a new study suggests. Researchers found that villagers in Ghana who had higher levels of cognitive and decision-making abilities - not just the most knowledge -- were the ones who were most likely to take steps to protect themselves from HIV infection...
9/9/2010 Novel Sensing Mechanism Discovered In Dendritic Cells To Increase Immune Response To HIV
Dendritic cells are the grand sentinels of the immune system, standing guard 24/7 to detect foreign invaders such as viruses and bacteria, and bring news of the invasion to other immune cells to marshal an attack. These sentinels, however, nearly always fail to respond adequately to HIV, the virus causing AIDS...
9/9/2010 Experts Gathered For UNAIDS, WHO Meeting Recommend Follow-Up Studies Of ARV-Containing Microbicide Gel Start Soon
Experts gathered at a joint meeting of UNAIDS and the WHO last week called for two additional clinical trials to test the effectiveness and safety of a microbicide vaginal gel containing the antiretroviral tenofovir, which previous studies have shown reduces the risk of HIV transmission in women who used it before and after sex by 39 percent, PANA/Afrique en ligne reports (9/5)...
9/9/2010 Funding Roadblocks Stall Progress On Vaginal Microbicide To Fight HIV
Donors have not committed enough money to move forward with two studies needed to confirm the efficacy of a vaginal microbicidal gel infused with the antiviral drug tenofovir to prevent HIV transmission in women, the New York Times reports...
9/9/2010 Switching To Nevirapine May Be Beneficial For Some HIV-Infected Children Who Have Achieved Viral Suppression
HIV-infected children in South Africa who were exposed to the drug nevirapine at birth (used to help prevent mother-to-child HIV transmission) and then received a protease inhibitor (PI) for viral suppression achieved lower rates of viremia (virus in the blood stream) if they were switched to nevirapine, compared to children who continued on the PI-based regimen, according to a...
9/9/2010 Also In Global Health News: India's Antibiotic Use; Abstinence Curriculum In China; Child, Maternal Health In India; Plumpy'nut; PEPFAR Funds - Uganda
India To Review Antibiotic Use; Japan Detects Resistant Gene Originally Found In South Asia "The health ministry has formed a committee to frame a policy for antibiotic use, following an uproar over a Lancet study that traced a drug-resistant bacterial superbug's origins to India," LiveMint.com reports...
9/9/2010 Are White Homosexual Men Still Taking Too Many HIV Risks?
Risky sexual behavior among members of a subset of the gay community is still adding to the spread of HIV. Research published in the open access journal BMC Infectious Diseases has found that young white homosexual men have an important contribution in the local spread of HIV...
9/9/2010 Road-Map Agreed For Confirmatory Trials Of Promising Microbicide
Two further clinical trials are planned to confirm a vaginal gel which has shown potential in reducing the risk of HIV. The results of the first trial of the gel, which were announced in July at the XVIII International AIDS Conference in Vienna, must be confirmed before the product can be made available for general use...
9/9/2010 Recent Releases In Global Health
Lancet Editorial Makes Recommendations For Health-System Strengthening "There is strong consensus in the global health community, among donors, recipient countries, and policy makers, about the need for health system strengthening in low-income and middle-income countries," write the authors of a Lancet Comment...
9/9/2010 The International AIDS Society Calls For An End To Harassment, Intimidation And Imprisonment Of HIV Professionals
Following the imprisonment of Maxim Popov in April 2010, sentenced to 7 years jail primarily for the promotion of HIV prevention efforts in Uzbekistan, the International AIDS Society (IAS) notes with alarm the detention of a medial practitioner working in HIV prevention in Ukraine. Dr...
9/9/2010 State News: Ohio, Florida Take Advantage Of Federal Health Funds; Mass. Psychiatrists Win Court Case
The Columbus Dispatch: "Gov. Ted Strickland's administration announced today that nearly $200 million in recently freed up state funds will go to Ohio hospitals, community mental health services, and a program which provides medication to low-income residents with HIV/AIDS. ...
9/9/2010 VOA News Examines U.S. Global Health Initiative
VOA News examines President Barack Obama's $63 billion Global Health Initiative (GHI), noting the initiative's emphasis on cost-effective strategies to improve child- and maternal-health as well as programs to fight HIV/AIDS, tuberculosis (TB) and malaria...
9/9/2010 Tibotec Pharmaceuticals Seeks European Marketing Authorization For Investigational Once-Daily HIV Treatment TMC278
Tibotec Pharmaceuticals announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV...
9/9/2010 Gilead Sciences Submits European Marketing Application For Once-Daily Single-Tablet Regimen Of Truvada® And TMC278 For The Treatment Of HIV Infect
Gilead Sciences, Inc...
9/9/2010 AVAC Calls For Speedy Funding Of Critical Microbicide Follow-Up Studies
AVAC issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible...
9/9/2010 A Scientific Breakthrough On How HIV Takes Control Of Cell Division
Dr. Eric A. Cohen, Director of the Human Retrovirology research unit at the Institut de recherches cliniques de Montreal (IRCM), and his team published yesterday, in the online open-access journal PLos Pathogens, the results of their most recent research on the role of the Vpr protein in HIV (human immunodeficiency virus) infection and AIDS (acquired autoimmune deficiency syndrome)...
9/9/2010 Commitments To Global HIV/AIDS Programs Falter For 'First Time In 15 Years,' UNAIDS Chief Says
UNAIDS Executive Director Michel Sidibe "said Thursday that global contributions to fighting [HIV/AIDS] are dropping off for the first time in 15 years amid tough economic times," Agence France-Presse reports. "The world economic recession is pushing countries ...
9/9/2010 Are HERVs An Answer To AIDS Mysteries?
Why is it so hard to isolate and purify human immunodeficiency virus (HIV)? Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load"? Why does HIV seem to mutate with startling rapidity? AIDS researchers have not been able to come up with answers to these questions...
9/9/2010 Research At GHESKIO Leads To Update In WHO Guidelines For HIV Treatment
Prompted by clinical research into the early initiation of antiretroviral therapies for HIV performed at the GHESKIO clinic in Port-au-Prince, Haiti, the World Health Organization (WHO) has revised its treatment protocols for HIV patients...
9/9/2010 Cheap And Accurate Tuberculosis Test Gives Results In Under Two Hours
A tuberculosis test, called Xpert® MTB/RIF, can successfully identify 98% of all culture-confirmed TB cases, including more than 90% of those with smear-negative disease, a study published in NEJM (New England Journal of Medicine) reveals...
9/9/2010 Also In Global Health News: China's First HIV Discrimination Case; Congo Mass Rape; S. Sudan Flooding; Kenya's Population Growth; Family Planning
Court Accepts China's First HIV Discrimination Case, State Media Reports "A municipal court in central China has accepted the country's first lawsuit alleging work discrimination because of HIV status, state media reported Tuesday," the Associated Press reports (8/31)...
|
CanMedGlobal.com advantages
Save 50 to 90% off your local pharmacy
No Membership Fees
We Ship Internationally
Fast Service, Fast delivery time
|
|
|
|
|
